ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
03 Mar 2017 02:06

Celltrion Healthcare IPO - Summary on Last Week's IPO Roadshow in HK & Singapore

Celltrion Healthcare just completed the pre-IPO roadshows in Hong Kong and Singapore last week. The company officials met about 15 institutional...

Logo
346 Views
Share
01 Mar 2017 10:02

Comprehensive List of Holdco Conversion Candidates in Korea

Holdco (holding company) conversion candidates in Korea have been some of the best performing stocks in Korea in the past six months. In this...

Logo
1.1k Views
Share
28 Feb 2017 17:16

Korea Stock Market Monthly Recap #11 - (February 2017)

Food for Thought - Is the major underperformance of semiconductor related stocks in Korea in February a short term blip or start of a major...

Logo
182 Views
Share
05 Feb 2017 16:08

Revisiting Samsung BioLogics at This Interesting Time

I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...

Logo
246 Views
Share
31 Jan 2017 22:29

Korea Stock Market Monthly Recap #10 - (January 2017)

The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...

Logo
321 Views
Share
x